Viewing Study NCT04629911



Ignite Creation Date: 2024-05-06 @ 3:25 PM
Last Modification Date: 2024-10-26 @ 1:49 PM
Study NCT ID: NCT04629911
Status: COMPLETED
Last Update Posted: 2022-01-05
First Post: 2020-11-10

Brief Title: High Flow Nasal Oxygenation and Gastric Insufflation in Anesthetized Patients
Sponsor: Ajou University School of Medicine
Organization: Ajou University School of Medicine

Study Overview

Official Title: The Effect of High Flow Nasal Oxygenation on Gastric Insufflation in Paralyzed Anesthetized Patients Undergoing Laryngologic Surgery
Status: COMPLETED
Status Verified Date: 2022-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Transnasal humidified rapid-insufflation ventilatory exchangeTHRIVE or also termed high flow nasal oxygenation HFNO is a method of supplying heated humidified high concentrations of oxygen via nasal cavity

The purpose of this study is to investigate the effect of HFNO on gastric insufflation in paralyzed anesthetized patients undergoing laryngologic surgery
Detailed Description: HFNO can be used during intraoperative period HFNO reduces the risk of desaturation and prolongs the safe apnea time compared with conventional oxygenation

In laryngeal microsurgery HFNO therapy make possible to perform tubeless anesthesia providing perfect exposure of structure of the vocal cords

HFNO have a risk for low level of positive pressure can make gastric distension but gastric reflux or aspiration were not occurred during rapid sequence induction for emergency operation

The purpose of this study is to investigate the effect of HFNO on gastric insufflation in paralyzed anesthetized patients undergoing laryngologic surgery

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None